| 摘要 |
The invention relates to a sulfated glycosaminoglycanoid derivative or a pharmaceutically acceptable salt thereof, of which the functional N-sulfate, N-acetate, and hydroxy groups, are replaced by alkoxy, aryloxy, aralkoxy, O-sulfate, or OALK(OALK)n OX groups (wherein ALK is an aliphatic hydrocarbon group, n is 0-5, and X is an alkyl or aryl group), provided that at least two functional groups are not replaced by O-sulfate. The compounds have antithrombotic and smooth muscle cell proliferation inhibiting activities.
|
